Combating COVID-19

What this fund achieved

Your support made it possible to reach people with lifesaving tools like diagnostics and vaccines, while supporting research and development to rapidly identify new innovations like therapeutics.

The impact you’ve helped influence

$18M

$18M invested to purchase COVID-19 vaccine doses for low-income countries through Gavi’s COVAX Advance Market Commitment.

150 million

5,000 diagnostics instruments have been sent to 49 countries around the world, expanding testing capabilities for COVID-19. Manufacturing capacity of this platform will scale to produce 150 million tests per year from 2022-2030.

10,000

In the hunt to find an effective treatment against COVID-19, scientists analyzed more than 10,000 compounds to find a match.

50

50 grants totaling over $128M were made to high-impact projects. These projects helped develop new tools for a sustained response, protect the most vulnerable populations, and ensure the equitable, timely delivery of lifesaving products.

Preventing and treating COVID-19 saved millions of lives.

Photo by Geert Vanden Wijngaert/Bloomberg via Getty Images

Photo by ABDIRAZAK HUSSEIN FARAH/AFP via Getty Images


The world needed more than great science to address the COVID-19 pandemic: it needed your compassion.

Combating COVID-19 allocated funds from March 2020–April 2022

COVID-19 has not just been a health emergency; it has been a social and economic crisis. Beyond developing and delivering vaccines and treatments, we provided much-needed funds to meet basic needs.

COVID Pie Chart Large
  1. Diagnostics – $3.40M

  2. Protecting the Most Vulnerable – $6.10M

  3. Vaccines – $26.14M

  4. COVID-19 Therapeutics Accelerator – $92.70M

Unsupported browser detected

Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.

Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.